Roy Eldor Selected Research

Creatinine

10/2021	[HEMOGLOBIN A1C AND MORTALITY FROM COVID-19].
1/2017	Sex difference in the risk for exercise-induced albuminuria correlates with hemoglobin A1C and abnormal exercise ECG test findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy Eldor Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 03/2024 - 04/2005
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 05/2009
6	Insulin Resistance 01/2017 - 11/2010
4	Diabetes Complications 03/2024 - 01/2019
4	Body Weight (Weight, Body) 01/2018 - 01/2018
3	Obesity 01/2023 - 12/2012
3	Inflammation (Inflammations) 01/2023 - 01/2015
3	Infections 10/2021 - 01/2018
3	Hyperglycemia 02/2014 - 05/2009
2	Cognitive Dysfunction 01/2024 - 01/2017
2	Albuminuria 01/2022 - 01/2017
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021 - 01/2021
2	Diabetes Mellitus 10/2021 - 02/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2016 - 08/2014
1	Weight Loss (Weight Reduction) 10/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Weight Gain 01/2023
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Ulcer 01/2022
1	Heart Failure 10/2021
1	Chronic Disease (Chronic Diseases) 10/2021
1	Dementia (Dementias) 10/2021
1	COVID-19 10/2021
1	Glycosuria 01/2019
1	Ketosis 01/2019
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Lactic Acidosis 01/2019
1	Disease Progression 01/2015
1	Hypertension (High Blood Pressure) 12/2012
1	Spinal Fractures 05/2012

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 03/2024 - 06/2005
9	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 04/2005
5	LipidsIBA 01/2024 - 04/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2015
3	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2021 - 02/2014
2	ORMD-0801IBA 01/2023 - 01/2013
2	CreatinineIBA 10/2021 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 01/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 05/2012
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2018
2	MK-1293IBA 01/2018 - 01/2018
2	ertugliflozinIBA 01/2018 - 01/2018
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 01/2018 - 01/2018
2	InsulinsIBA 01/2018 - 01/2018
2	dapagliflozinIBA 11/2016 - 02/2014
2	Adenosine Triphosphate (ATP)IBA 11/2016 - 08/2014
1	semaglutideIBA 10/2023
1	C-Reactive ProteinIBA 01/2023
1	VaccinesIBA 10/2021
1	Vitamin D FDA LinkGeneric 10/2021
1	VitaminsIBA 10/2021
1	IronIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	ElectrolytesIBA 01/2019
1	empagliflozinIBA 01/2019
1	Apolipoprotein E4IBA 01/2017
1	AlbuminsIBA 01/2017
1	Glucagon (Glukagon)FDA Link 11/2016
1	KetonesIBA 11/2016
1	Nonesterified Fatty Acids (NEFA)IBA 08/2014
1	Sodium-Glucose Transport ProteinsIBA 02/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2013
1	Blood Glucose (Blood Sugar)IBA 01/2013
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2012
1	SecretagoguesIBA 12/2012
1	Protein Kinase C-alphaIBA 08/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2010
1	AntigensIBA 05/2009

Therapy/Procedure

3	Therapeutics 10/2023 - 12/2012
3	Glycemic Control 01/2022 - 08/2013
1	Ambulatory Care (Outpatient Care) 01/2024
1	Off-Label Use 10/2023
1	Surgical Amputation (Amputations) 01/2022
1	Caloric Restriction 01/2019
1	Resistance Training 01/2019
1	Mediterranean Diet 01/2019
1	Transplantation 01/2013